# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA621039 | F | Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01) | Homo sapiens | 14 | ALA1125438 | cell-based format | Scientific Literature | |
2. | ALA621040 | F | Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01); Not active | Homo sapiens | 6 | ALA1125438 | cell-based format | Scientific Literature | |
3. | ALA655795 | F | Antiviral activity in CD-4+ (A 3.01) cell line expressed as CC50 | 1 | ALA1129925 | cell-based format | Scientific Literature | ||
4. | ALA655796 | F | Antiviral activity in CD-4+ (A 3.01) cell line expressed as IC50 | 1 | ALA1129925 | cell-based format | Scientific Literature | ||
5. | ALA689801 | F | In vitro Cytotoxic concentration which destroyed HIV-1 LAV infected H9 cells completely | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
6. | ALA689802 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected H9 cells by 25 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
7. | ALA689112 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected H9 cells by 50 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
8. | ALA690740 | F | In vitro inhibitory activity against HIV was determined | Human immunodeficiency virus | 1 | ALA1127324 | organism-based format | Scientific Literature | |
9. | ALA711392 | F | In vitro Cytotoxic concentration which destroyed HIV-1 LAV infected MT-2 cells completely | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
10. | ALA711393 | F | In vitro Cytotoxic concentration which destroyed HIV-1 LAV infected peripheral blood lymphocytes (PBL) completely | Homo sapiens | 1 | ALA1125438 | cell-based format | Scientific Literature | |
11. | ALA711394 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected MT-2 cells by 25 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
12. | ALA711410 | F | In vitro Cytotoxic concentration which reduced G 691-2(post-AZT) infected MT-2 cells by 50 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
13. | ALA711411 | F | In vitro Cytotoxic concentration which reduced G 762-3(pre-AZT) infected MT-2 cells by 50 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
14. | ALA711412 | F | In vitro Cytotoxic concentration which reduced G 910-6p2 (post-AZT) infected MT-2 cells by 50 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
15. | ALA873359 | F | In vitro Cytotoxic concentration which reduced H 112-2(pre-AZT) infected MT-2 cells by 50 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
16. | ALA712335 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected MT-2 cells by 50 percent | Homo sapiens | 2 | ALA1125438 | cell-based format | Scientific Literature | |
17. | ALA733115 | F | In vitro Cytotoxic concentration in mock-infected A3.01 cells. | Homo sapiens | 17 | ALA1125438 | cell-based format | Scientific Literature | |
18. | ALA731739 | F | In vitro Cytotoxic concentration in mock-infected A3.01 cells - 100% toxicity. | Homo sapiens | 17 | ALA1125438 | cell-based format | Scientific Literature | |
19. | ALA767192 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected peripheral blood lymphocytes (PBL) by 25 percent | 2 | ALA1125438 | assay format | Scientific Literature | ||
20. | ALA767193 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected peripheral blood lymphocytes by 50 percent | 2 | ALA1125438 | assay format | Scientific Literature |